WCA
IBB icon

Waratah Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Waratah Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-33,225
Closed -$3.36M – 193
2015
Q3 		$3.36M Buy
+33,225
New +$3.99M 0.71% 40

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Waratah Capital Advisors's IBB Position: Q4 2015 in Review

Waratah Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2015, closing a stake of 33,225 shares — an estimated $3.36M sold.

Waratah Capital Advisors first reported a position in IBB in Q3 2015 and held it in 1 quarter. The position peaked at $3.36M in Q3 2015. 432 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

  • Waratah Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2015 after selling out during the quarter.
  • Waratah Capital Advisors sold 33,225 iShares Biotechnology ETF shares in Q4 2015, an estimated $3.36M.
  • Waratah Capital Advisors first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 1 quarter.
  • Waratah Capital Advisors's iShares Biotechnology ETF position peaked at $3.36M in Q3 2015.
  • 432 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Waratah Capital Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.